Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
PBH 
Prestige Brand Holdings Inc (PBH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/23/2025: PBH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
7 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $80.83
1 Year Target Price $80.83
| 3 | Strong Buy |
| 0 | Buy |
| 3 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -11.39% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.08B USD | Price to earnings Ratio 14.68 | 1Y Target Price 80.83 |
Price to earnings Ratio 14.68 | 1Y Target Price 80.83 | ||
Volume (30-day avg) 7 | Beta 0.44 | 52 Weeks Range 60.15 - 90.04 | Updated Date 10/24/2025 |
52 Weeks Range 60.15 - 90.04 | Updated Date 10/24/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.24 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 19.02% | Operating Margin (TTM) 28.76% |
Management Effectiveness
Return on Assets (TTM) 6.47% | Return on Equity (TTM) 12.05% |
Valuation
Trailing PE 14.68 | Forward PE 13.85 | Enterprise Value 3995840505 | Price to Sales(TTM) 2.75 |
Enterprise Value 3995840505 | Price to Sales(TTM) 2.75 | ||
Enterprise Value to Revenue 3.57 | Enterprise Value to EBITDA 11.04 | Shares Outstanding 49214171 | Shares Floating 48647224 |
Shares Outstanding 49214171 | Shares Floating 48647224 | ||
Percent Insiders 1.26 | Percent Institutions 106.88 |
Upturn AI SWOT
Prestige Brand Holdings Inc
Company Overview
History and Background
Prestige Consumer Healthcare Inc. (formerly Prestige Brand Holdings, Inc.) was founded in 1996. It has grown through acquisitions of various over-the-counter healthcare brands. The company focuses on acquiring and marketing brands with strong consumer loyalty.
Core Business Areas
- North American Over-the-Counter (OTC) Healthcare: This segment focuses on marketing and distributing OTC healthcare products in North America.
- International OTC Healthcare: This segment focuses on marketing and distributing OTC healthcare products internationally.
Leadership and Structure
The leadership team consists of the CEO, CFO, and other key executives. The organizational structure typically involves functional departments such as marketing, sales, finance, and operations.
Top Products and Market Share
Key Offerings
- Clear Eyes: Clear Eyes is a brand of eye drops used to relieve redness and dryness. Market share varies; data is not publicly available but it's a leading product in the eye care category. Competitors include Visine, Refresh, and Systane.
- BC/Goody's Powder: BC and Goody's are brands of headache powders. Market share varies geographically; data is not publicly available, but it is a major product. Competitors include Excedrin, Bayer, and other pain relievers.
- Compound W: Compound W is a brand of wart remover. It holds a significant market share in the wart removal category, typically over 50%. Competitors include Dr. Scholl's and other OTC wart treatments. Revenue unavailable.
- Summer's Eve: Summer's Eve is a brand of feminine hygiene products. It has a substantial market share in its category, often leading. Competitors include Vagisil, Always, and other feminine hygiene brands. Revenue unavailable.
Market Dynamics
Industry Overview
The OTC healthcare industry is characterized by stable growth driven by aging populations, increasing self-medication trends, and innovation in product formulations. The industry is competitive, with both large pharmaceutical companies and smaller specialty brands vying for market share.
Positioning
Prestige Consumer Healthcare positions itself as a consolidator of established, consumer-trusted OTC brands. Its competitive advantage lies in its brand portfolio and distribution network.
Total Addressable Market (TAM)
The global OTC market is estimated at hundreds of billions of dollars. Prestige Consumer Healthcare is positioned to capture a portion of this TAM through strategic acquisitions and brand management.
Upturn SWOT Analysis
Strengths
- Strong brand portfolio
- Established distribution network
- Proven acquisition strategy
- High consumer brand loyalty
Weaknesses
- High debt levels due to acquisitions
- Reliance on a limited number of key brands
- Potential for product liability issues
- Vulnerable to private label brands
Opportunities
- Further acquisitions of complementary brands
- Expansion into new geographic markets
- Development of new product formulations
- Increased online sales
Threats
- Increased competition from larger pharmaceutical companies
- Changes in consumer preferences
- Regulatory changes
- Economic downturn
Competitors and Market Share
Key Competitors
- Johnson & Johnson (JNJ)
- Procter & Gamble (PG)
- Bayer (BAYRY)
Competitive Landscape
Prestige Consumer Healthcare faces intense competition from larger companies with greater resources. Its advantage lies in its focused brand portfolio and acquisition strategy.
Major Acquisitions
Black Diamond Group (Compeed)
- Year: 2023
- Acquisition Price (USD millions): 660
- Strategic Rationale: Expands international presence and strengthens position in skin health.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by acquisitions and organic growth of existing brands.
Future Projections: Analyst estimates typically project continued growth through acquisitions and organic growth.
Recent Initiatives: Recent strategic initiatives may include new product launches, marketing campaigns, and acquisitions.
Summary
Prestige Consumer Healthcare is a company with a proven acquisition strategy and a strong portfolio of consumer brands. However, it faces high debt levels and competition from larger players. The company's future growth depends on its ability to successfully integrate acquisitions and grow its existing brands.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Industry Reports
- Market Research Data
Disclaimers:
The information provided is for informational purposes only and does not constitute investment advice. Market share data is estimated.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Prestige Brand Holdings Inc
Exchange NYSE | Headquaters Tarrytown, NY, United States | ||
IPO Launch date 2005-02-10 | Chairman, President & CEO Mr. Ronald M. Lombardi CPA | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 600 | Website https://www.prestigebrands.com |
Full time employees 600 | Website https://www.prestigebrands.com | ||
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under Debrox brand name. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.